Effectiveness and Safety of Alcohol-Free Minoxidil in Androgenetic Alopecia Treatment

The study "Effectiveness and safety of alcohol-free minoxidil in the management of treatment-naive patients with androgenetic alopecia" involved 53 male patients aged 18 to 45 years with androgenetic alopecia (AGA). The study found that alcohol-free minoxidil 5% was effective and safe for treating AGA. The anagen/telogen ratio (ATR), hair density, and hair shaft thickness improved significantly from day 90 to day 180 of treatment. The investigator assessment for effectiveness was 'excellent'/'good'/'satisfactory' for 90% of patients, which was in line with the patients' assessment (90%) at day 180. All the investigators and patients indicated that minoxidil had 'good' tolerability for all patients. No adverse events were reported during the study.